Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $64.5B
1-Year Est. Return 42.74%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$64.5B
AUM Growth
-$11.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,923
New
Increased
Reduced
Closed

Top Buys

1 +$616M
2 +$481M
3 +$416M
4
TSLA icon
Tesla
TSLA
+$416M
5
PG icon
Procter & Gamble
PG
+$322M

Top Sells

1 +$885M
2 +$660M
3 +$463M
4
APP icon
Applovin
APP
+$430M
5
META icon
Meta Platforms (Facebook)
META
+$354M

Sector Composition

1 Technology 20.85%
2 Healthcare 15.77%
3 Consumer Discretionary 13.88%
4 Industrials 9.93%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAVE icon
3476
Global X US Infrastructure Development ETF
PAVE
$11.8B
-5,000
QCOM icon
3477
Qualcomm
QCOM
$136B
-83,261
RANI icon
3478
Rani Therapeutics
RANI
$80.3M
-24,908
RBBN icon
3479
Ribbon Communications
RBBN
$385M
-38,800
RBC icon
3480
RBC Bearings
RBC
$17.5B
-8,000
REM icon
3481
iShares Mortgage Real Estate ETF
REM
$550M
-18,000
REMX icon
3482
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.62B
-27,900
LNAI
3483
Lunai Bioworks
LNAI
$9.97M
-37,761
RERE
3484
ATRenew
RERE
$1.04B
-276,000
RGEN icon
3485
Repligen
RGEN
$6.67B
-109,404
RKT icon
3486
Rocket Companies
RKT
$40.7B
-3,431,394
RLI icon
3487
RLI Corp
RLI
$5.23B
-219,900
RLX icon
3488
RLX Technology
RLX
$2.67B
-869,300
RMCO icon
3489
Royalty Management
RMCO
$45M
-15,600
ROST icon
3490
Ross Stores
ROST
$71.1B
-214,633
RTO icon
3491
Rentokil
RTO
$16.1B
-50,400
RVMD icon
3492
Revolution Medicines
RVMD
$19.5B
-253,104
RVPH icon
3493
Reviva Pharmaceuticals
RVPH
$10.4M
-216,597
RVYL icon
3494
Ryvyl
RVYL
$7.32M
-1,346
RXST icon
3495
RxSight
RXST
$262M
-138,700
RYLD icon
3496
Global X Russell 2000 Covered Call ETF
RYLD
$1.27B
-37,900
SABS icon
3497
SAB Biotherapeutics
SABS
$272M
-80,840
SAND
3498
DELISTED
Sandstorm Gold
SAND
-1,625,700
SARK icon
3499
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$75.9M
-15,900
SBFM
3500
Sunshine Biopharma
SBFM
$5.37M
-55,700